CAPTAIN Trial Comparing Profound’s MRI-Guided TULSA ProcedureTM to Robotic Radical Prostatectomy Successfully Meets Primary Safety Endpoint, Preservation of Erectile Function and Urinary Continence

AI Briefing

• – New MRI-guided TULSA procedure shows promise in preserving erectile function and urinary continence in prostate cancer patients.
• – This technology is being compared to robotic radical prostatectomy in a multicenter trial.
• – The trial aims to recruit to target enrollment to compare the two treatments.